title: Demyelinating disease and psoriasis: interferon versus dimethyl fumarate.
authors.affiliation: MaineGeneral Neurology, United States; MaineGeneral Medical Center, United States.
authors.forename: Lynn G
authors.initials: LG
authors.lastname: Howard
authors.affiliation: MaineGeneral Neurology, United States; MaineGeneral Medical Center, United States. Electronic address: rbomprez@gmail.com.
authors.forename: Roberto
authors.initials: R
authors.lastname: Bomprezzi
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003711:Demyelinating Diseases / Q000150:complications / Q000188:drug therapy*; D000069462:Dimethyl Fumarate; D005650:Fumarates / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000998:Antiviral Agents; D005650:Fumarates; D007166:Immunosuppressive Agents; D007372:Interferons; D000069462:Dimethyl Fumarate
keywords: Demyelinating disease; Dimethyl fumarate; Interferon; Psoriasis